| Literature DB >> 29643055 |
Lauren B Sherar1,2,3, Sally J Singh4,1,2, Mark W Orme4,1,2, Amie E Weedon5, Paula M Saukko5, Dale W Esliger1,2,3, Mike D Morgan4, Michael C Steiner4,1,2, John W Downey5.
Abstract
BACKGROUND: Targeting sedentary time post exacerbation may be more relevant than targeting structured exercise for individuals with chronic obstructive pulmonary disease. Focusing interventions on sitting less and moving more after an exacerbation may act as a stepping stone to increase uptake to pulmonary rehabilitation.Entities:
Keywords: chronic obstructive pulmonary disease; feasibility; fitness trackers; intervention; physical activity; sedentary lifestyle; sedentary time; self-monitoring; wearable electronic devices
Year: 2018 PMID: 29643055 PMCID: PMC5917078 DOI: 10.2196/mhealth.9398
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Figure 1A concept diagram demonstrating where vibration prompts (set for 30 consecutive minutes sedentary) would occur during the course of a day. The dashed lines indicate where a vibration prompt would have occurred. The darker shaded areas depict where a patient has interrupted their sedentary time with standing and/or walking, and the black bars represent step count. Prompts at 9:30, 14:45, 16:30, 21:00 and 22:15 are followed by physical activity within 5 min of the prompt taking place. Prompts at 18:45, 19:15, 19:45 (3 consecutive prompts) and 21:45 are not followed by physical activity.
Figure 2Consolidated Standards of Reporting Trials (CONSORT) diagram.
Patient characteristics for the whole sample and stratified by attendance at the 2-week follow-up appointment. COPD: chronic obstructive pulmonary disease.
| Descriptor | Whole sample (N=33) | Completed (N=17) | Not completed (N=16) | |
| Age in years, mean (SD) | 71.0 (20.0) | 66.6 (9.6) | 69.5 (11.2) | |
| Female sex, n (%) | 23 (70) | 12 (71) | 11 (69) | |
| Index of Multiple Deprivation decile, mean (SD) | 4.5 (3.2) | 5.8 (3.1) | 3.0 (2.6); | |
| Retired | 25 (76) | 12 (71) | 13 (81) | |
| Unemployed | 5 (15) | 4 (24) | 1 (6) | |
| Employed | 3 (9) | 1 (6) | 2 (13) | |
| Current | 11 (34) | 4 (24) | 7 (44) | |
| Former | 21 (66) | 12 (71) | 9 (56) | |
| Pack years, mean (SD) | 46.7 (25.6) | 44.3 (26.5) | 49.5 (25.1) | |
| Usual modified Medical Research Council grade, mean (SD) | 2.6 (1.2) | 2.7 (1.1) | 2.6 (1.3) | |
| Home oxygen, n (%) | 3 (9) | 2 (12) | 1 (6) | |
| Number of comorbidities, mean (SD) | 3 (3) | 2 (3) | 4 (3) | |
| Acute exacerbation of COPD readmissions, n (%) | 4 (12) | 0 (0) | 4 (25); | |
| COPD assessment test score, mean (SD) | 24.9 (7.5) | 24.5 (7.4) | 25.4 (7.8) | |
| Fatigue score, mean (SD) | 19.8 (11.8) | 21.0 (12.2) | 18.1 (11.7) | |
| Hospital Anxiety and Depression Scale depression score, mean (SD) | 8.2 (4.7) | 7.4 (5.2) | 9.3 (3.9) | |
| Hospital Anxiety and Depression Scale anxiety score, mean (SD) | 9.2 (5.8) | 8.9 (5.5) | 9.6 (6.2) | |
| Falls Efficacy Scale-International score, mean (SD) | 33.4 (13.7) | 31.5 (13.5) | 35.4 (14.2) | |
| Self-reported daily sitting time in min/day, mean (SD) | 553.0 (253.6) | 603.1 (257.4) | 487.9 (245.9) | |
aMissing n=1.
Figure 3Behavioral responses to the vibration prompt for the 5 min following the prompt occurring.
Uptake to pulmonary rehabilitation (PR) stratified by study group.
| Stage of pulmonary rehabilitation | Whole sample (N=33) | Control (N=11) | Education (N=10) | Education+Feedback (N=12) |
| Attended clinic assessment, n (%) | 14 (42 | 8 (73) | 3 (30) | 3 (25) |
| Agreed to take part in PR, n (%) | 7 (21) | 3 (27) | 2 (20) | 2 (17) |
| Attended PR, n (%) | 4 (12) | 1 (9) | 1 (10) | 2 (17) |
Figure 4Daily step count during the 14-day study period for patients with valid data (≥4 day out of a possible 7 for each of the 2 weeks). N=8 for day 7 and day 8; N=7 for day 2, day 3, day 4, day 9, day 12, and day 13; N=6 for day 1, day 5, day 6, and day 11; and N=5 for day 10.
Figure 5Proportion of each waking day spent being stationary, in light activity and in moderate to vigorous physical activity (MVPA) during the 14-day study period for patients with ≥4 valid days for each of the 2 weeks. N=8 for day 7 and day 8; N=7 for day 2, day 3, day 4, day 9, day 12, and day 13; N=6 for day 1, day 5, day 6 and day 11; and N=5 for day 10.